Compare BWIN & NKTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BWIN | NKTR |
|---|---|---|
| Founded | 2011 | 1990 |
| Country | United States | United States |
| Employees | 5020 | N/A |
| Industry | Specialty Insurers | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.8B | 2.1B |
| IPO Year | N/A | 1996 |
| Metric | BWIN | NKTR |
|---|---|---|
| Price | $19.64 | $57.16 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 7 | 7 |
| Target Price | $30.43 | ★ $146.67 |
| AVG Volume (30 Days) | ★ 1.3M | 891.7K |
| Earning Date | 05-04-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $307,711,000.00 |
| Revenue This Year | $36.36 | N/A |
| Revenue Next Year | $10.82 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 86.00 |
| 52 Week Low | $15.88 | $7.99 |
| 52 Week High | $43.25 | $109.00 |
| Indicator | BWIN | NKTR |
|---|---|---|
| Relative Strength Index (RSI) | 43.81 | 21.72 |
| Support Level | $19.30 | $52.99 |
| Resistance Level | $23.24 | $61.98 |
| Average True Range (ATR) | 1.06 | 2.84 |
| MACD | 0.03 | -0.96 |
| Stochastic Oscillator | 26.90 | 0.88 |
The Baldwin Insurance Group Inc is an insurance distribution company operating in the United States. The company provides commercial risk management, employee benefits, private risk management, and personal insurance solutions. It operates through three segments: Insurance Advisory Solutions, which focuses on commercial risk management and employee benefits; Underwriting, Capacity & Technology Solutions, which includes managing general agency operations, reinsurance brokerage, captive management, and technology-enabled insurance products; and Mainstreet Insurance Solutions, which offers personal, commercial, and life and health insurance products through community-based distribution channels.
Nektar Therapeutics is a clinical-stage, research-based drug discovery biopharmaceutical company focused on discovering and developing medicines in the field of immunotherapy. The company is focused on discovering and developing medicines in the field of immunotherapy. Its pipeline products are REZPEG (NKTR-358), REZPEG (NKTR-358), REZPEG (NKTR-358), NKTR-422, NKTR-0165, NKTR-255, and Others.